{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:32:28Z","timestamp":1761323548493,"version":"3.34.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1176\/appi.psy.49.2.168","type":"journal-article","created":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T19:28:17Z","timestamp":1205954897000},"page":"168-175","source":"Crossref","is-referenced-by-count":18,"title":["Oral Contraceptives"],"prefix":"10.1016","volume":"49","author":[{"given":"Jessica R.","family":"Oesterheld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Cozza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil B.","family":"Sandson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1176\/appi.psy.49.2.168_bib0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/j.1552-4604.1997.tb04781.x","article-title":"Biotransformation of mestranol to ethinyl estradiol in vitro: the role of cytochrome P450 2C9 and metabolic inhibitors","volume":"37","author":"Schmider","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0010","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/0024-3205(90)90431-P","article-title":"Metabolism of 17-alpha-ethynylestradiol in humans","volume":"47","author":"Guengerich","year":"1990","journal-title":"Life Sci"},{"key":"10.1176\/appi.psy.49.2.168_bib0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00003088-200746020-00003","article-title":"Pharmacokinetic drug interactions involving 17-alpha-ethinylestradiol: a new look at an old drug","volume":"46","author":"Zhang","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1176\/appi.psy.49.2.168_bib0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/oxfordjournals.jncimonographs.a024234","article-title":"Estrogen metabolism by conjugation","volume":"27","author":"Raftogianis","year":"2000","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1176\/appi.psy.49.2.168_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1749-6632.2001.tb03985.x","article-title":"Biochemistry and reproductive endocrinology of estrogen sulfotransferase","volume":"948","author":"Song","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1176\/appi.psy.49.2.168_bib0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/bbrc.2002.6658","article-title":"Catecholestrogen sulfation: possible role in carcinogenesis","volume":"292","author":"Adjei","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1176\/appi.psy.49.2.168_bib0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2125.2005.02382.x","article-title":"The role of CYP2C and CYP3A in the disposition of 3-keto-desogestrel after administration of desogestrel","volume":"60","author":"Korhonen","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0040","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/bmj.288.6424.1125-a","article-title":"Interaction between oral contraceptives and griseofulvin","volume":"288","author":"van Dijke","year":"1984","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1176\/appi.psy.49.2.168_bib0045","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0010-7824(80)90034-7","article-title":"A study of interaction of a low-dose combination oral contraceptive with anti-tubercular drugs","volume":"21","author":"Joshi","year":"1980","journal-title":"Contraception"},{"key":"10.1176\/appi.psy.49.2.168_bib0050","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0009-9236(99)70138-4","article-title":"The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive","volume":"65","author":"Barditch-Crovo","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0055","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/00912709922007985","article-title":"Effect of troglitazone on the pharmacokinetics of an oral contraceptive agent","volume":"39","author":"Loi","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00007691-198503000-00004","article-title":"Oral contraceptive drug interactions","volume":"7","author":"Baciewicz","year":"1985","journal-title":"Ther Drug Monit"},{"key":"10.1176\/appi.psy.49.2.168_bib0065","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1528-1157.1999.tb00779.x","article-title":"Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women","volume":"40","author":"Fattore","year":"1999","journal-title":"Epilepsia"},{"issue":"12,suppl 4","key":"10.1176\/appi.psy.49.2.168_bib0070","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1212\/WNL.67.12_suppl_4.S56","article-title":"Optimizing therapy of seizures in women who use oral contraceptives","volume":"67","author":"Harden","year":"2006","journal-title":"Neurology"},{"key":"10.1176\/appi.psy.49.2.168_bib0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0890-6238(01)00199-X","article-title":"The teratogenic effect of carbamazepine: a meta-analysis of 1,255 exposures","volume":"16","author":"Matalon","year":"2002","journal-title":"Reprod Toxicol"},{"key":"10.1176\/appi.psy.49.2.168_bib0080","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2165\/00003088-200443120-00001","article-title":"Pharmacokinetic interactions of topiramate","volume":"43","author":"Bialer","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1176\/appi.psy.49.2.168_bib0085","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1528-1157.1997.tb01123.x","article-title":"Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy","volume":"38","author":"Rosenfeld","year":"1997","journal-title":"Epilepsia"},{"key":"10.1176\/appi.psy.49.2.168_bib0090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0009-9236(95)90172-8","article-title":"Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive","volume":"58","author":"Saano","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2125.1998.00749.x","article-title":"Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers","volume":"46","author":"Ouellet","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0100","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00126334-200204150-00007","article-title":"Pharmacokinetic interaction between nevirapine and ethinylestradiol\/norethindrone when administered concurrently to HIV-infected women","volume":"29","author":"Mildvan","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1176\/appi.psy.49.2.168_bib0105","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1073\/pnas.130155097","article-title":"St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor","volume":"97","author":"Moore","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1176\/appi.psy.49.2.168_bib0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.contraception.2004.11.004","article-title":"Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity, and breakthrough bleeding","volume":"71","author":"Murphy","year":"2005","journal-title":"Contraception"},{"key":"10.1176\/appi.psy.49.2.168_bib0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1331\/1544-3191.47.1.42.Sarino","article-title":"Drug interactions between oral contraceptives and St. John's Wort: appropriateness of advice received from community pharmacists and health-food store clerks","volume":"47","author":"Sarino","year":"2007","journal-title":"J Am Pharm Assoc (Washington, DC)."},{"key":"10.1176\/appi.psy.49.2.168_bib0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1067\/mcp.2002.121217","article-title":"Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers","volume":"71","author":"Robertson","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0010-7824(86)90028-4","article-title":"The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids","volume":"33","author":"Crawford","year":"1986","journal-title":"Contraception"},{"key":"10.1176\/appi.psy.49.2.168_bib0130","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1212\/WNL.50.4.1146","article-title":"Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol","volume":"50","author":"Eldon","year":"1998","journal-title":"Neurology"},{"key":"10.1176\/appi.psy.49.2.168_bib0135","unstructured":"Holdich T, Whiteman P, Orme M, et al. Effect of lamotrigine on the pharmacology of the combined oral contraceptive pill (abstract). Epilepsia 1991; 32(suppl 1):96."},{"key":"10.1176\/appi.psy.49.2.168_bib0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2125.1997.00594.x","article-title":"Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring data","volume":"43","author":"Hussein","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1528-1167.2007.00983.x","article-title":"Pharmacokinetics and drug interactions with zonisamide","volume":"48","author":"Sills","year":"2007","journal-title":"Epilepsia"},{"key":"10.1176\/appi.psy.49.2.168_bib0150","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1528-1157.1997.tb01240.x","article-title":"A double-blind, placebo-controlled study on the effect of vigabatrin on in-vivo parameters of hepatic microsomal enzyme induction and on the kinetics of steroid oral contraceptives in healthy female volunteers","volume":"38","author":"Bartoli","year":"1997","journal-title":"Epilepsia"},{"key":"10.1176\/appi.psy.49.2.168_bib0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/j.1552-4604.1998.tb04399.x","article-title":"Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4","volume":"38","author":"Venkatakrishnan","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0160","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1177\/009127009803801208","article-title":"Preliminary evaluation of progestins as inducers of cytochrome P450 3A4 activity in postmenopausal women","volume":"38","author":"Tsunoda","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5414\/CPP44113","article-title":"Pharmacokinetic interaction between bosentan and the oral contraceptives norethisterone and ethinyl estradiol","volume":"44","author":"van Giersbergen","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0170","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.clpt.2004.01.003","article-title":"The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone","volume":"75","author":"Hendrix","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0175","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1345\/aph.1H395","article-title":"Absence of effect of oral rifaximin on the pharmacokinetics of ethinyl estradiol\/norgestimate in healthy females","volume":"41","author":"Trapnell","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1176\/appi.psy.49.2.168_bib0180","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/j.1875-9114.1998.tb03161.x","article-title":"Enhanced metabolism of levonorgestrel during phenobarbital treatment and resultant pregnancy","volume":"18","author":"Shane-McWhorter","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1176\/appi.psy.49.2.168_bib0185","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0010-7824(86)90044-2","article-title":"Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment","volume":"33","author":"Haukkamaa","year":"1986","journal-title":"Contraception"},{"key":"10.1176\/appi.psy.49.2.168_bib0190","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0010-7824(86)90018-1","article-title":"Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with Norplant implants","volume":"33","author":"Odlind","year":"1986","journal-title":"Contraception"},{"key":"10.1176\/appi.psy.49.2.168_bib0195","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2125.1990.tb05457.x","article-title":"The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids","volume":"30","author":"Crawford","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0200","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ogc.2007.02.001","article-title":"Contraception for women with chronic medical conditions","volume":"34","author":"Teal","year":"2007","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"suppl 1","key":"10.1176\/appi.psy.49.2.168_bib0205","first-page":"838","article-title":"Hormonal contraception and epilepsy","volume":"53","author":"Guberman","year":"1999","journal-title":"Neurology"},{"key":"10.1176\/appi.psy.49.2.168_bib0210","unstructured":"(No authors):Use of rifampin and contraceptive steroids. Br J Fam Plan 1999; 24:169\u2013170"},{"key":"10.1176\/appi.psy.49.2.168_bib0215","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0029-7844(01)01443-0","article-title":"Evaluation of interaction between fluconazole and an oral contraceptive in healthy women","volume":"98","author":"Hilbert","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1176\/appi.psy.49.2.168_bib0220","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0002-9378(98)80016-1","article-title":"The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives","volume":"178","author":"Sinofsky","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1176\/appi.psy.49.2.168_bib0225","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/clpt.1990.92","article-title":"A model to detect interactions between roxithromycin and oral contraceptives","volume":"47","author":"Meyer","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0230","first-page":"449","article-title":"Effects of macrolide antibiotics on drug metabolism in rats and in humans","volume":"3","author":"Pessayre","year":"1983","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1176\/appi.psy.49.2.168_bib0235","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0029-7844(95)00075-3","article-title":"Dirithromycin increases ethinyl estradiol clearance without allowing ovulation","volume":"86","author":"Wermeling","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1176\/appi.psy.49.2.168_bib0240","first-page":"191","article-title":"Norethisterone and ethinyl estradiol kinetics during dapsone therapy","volume":"32","author":"Joshi","year":"1984","journal-title":"J Assoc Physicians India"},{"key":"10.1176\/appi.psy.49.2.168_bib0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0010-7824(95)00252-9","article-title":"Can grapefruit juice influence ethinylestradiol bioavailability?","volume":"53","author":"Weber","year":"1996","journal-title":"Contraception"},{"key":"10.1176\/appi.psy.49.2.168_bib0250","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/0002-9378(90)90557-N","article-title":"Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs","volume":"163","author":"Guengerich","year":"1990","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl 2","key":"10.1176\/appi.psy.49.2.168_bib0255","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0010-7824(00)00147-5","article-title":"Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?","volume":"62","author":"Lawrenson","year":"2000","journal-title":"Contraception"},{"key":"10.1176\/appi.psy.49.2.168_bib0260","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/00004714-200112000-00015","article-title":"A probable interaction between a very-low-dose oral contraceptive and the antidepressant nefazodone: a case report","volume":"21","author":"Adson","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0265","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0006-2952(96)00501-1","article-title":"Studies of flurbiprofen 4\u2032-hydroxylation: additional evidence suggesting the sole involvement of cytochrome P450 2C9","volume":"52","author":"Tracy","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0270","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1124\/dmd.30.6.631","article-title":"Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively","volume":"30","author":"Wen","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1176\/appi.psy.49.2.168_bib0275","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1742-7843.2007.00061.x","article-title":"Inhibitory effect of valproic acid on cytochrome P450 2C9 activity in epilepsy patients","volume":"100","author":"Gunes","year":"2007","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1176\/appi.psy.49.2.168_bib0280","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1067\/mcp.2001.114229","article-title":"Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride","volume":"69","author":"Niemi","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0285","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF00544361","article-title":"Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives","volume":"28","author":"Abernethy","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0290","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00008571-199204000-00004","article-title":"Biotransformation of caffeine, paraxanthine, theobromine, and theophylline by cDNAexpressed human CYP1A2 and CYP2E1","volume":"2","author":"Gu","year":"1992","journal-title":"Pharmacogenetics"},{"key":"10.1176\/appi.psy.49.2.168_bib0295","first-page":"821","article-title":"Oral contraceptive steroids impair the elimination of theophylline","volume":"101","author":"Roberts","year":"1983","journal-title":"J Lab Clin Med"},{"key":"10.1176\/appi.psy.49.2.168_bib0300","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00545966","article-title":"Effect of chronic oral contraceptive steroids on theophylline disposition","volume":"23","author":"Tornatore","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0305","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-2952(95)00120-O","article-title":"Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation","volume":"50","author":"Zhang","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0310","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/0091-6749(86)90054-0","article-title":"Therapeutic consequences of drug interactions with theophylline pharmacokinetics","volume":"78","author":"Jonkman","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1176\/appi.psy.49.2.168_bib0315","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2125.1995.tb04472.x","article-title":"Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers: N-desisopropylation is mediated mainly by CYP1A2","volume":"39","author":"Yoshimoto","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0320","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2125.1996.03097.x","article-title":"Stimulatory as well as inhibitory effects of ethinyloestradiol on the metabolic clearances of propranolol in young women","volume":"41","author":"Walle","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0325","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/clpt.1989.136","article-title":"Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects","volume":"46","author":"Walle","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0330","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00004714-200212000-00013","article-title":"Clozapine and oral contraceptives: a possible drug interaction","volume":"22","author":"Gabbay","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0335","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00007691-200110000-00011","article-title":"Oral contraceptives increase the plasma concentrations of chlorpromazine","volume":"23","author":"Chetty","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1176\/appi.psy.49.2.168_bib0340","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/cp.1999.v66.103404001","article-title":"Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy","volume":"66","author":"Laine","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0345","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clpt.2005.06.009","article-title":"Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2","volume":"78","author":"Granfors","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0350","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0009-9236(03)00202-9","article-title":"Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation","volume":"74","author":"Palovaara","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0355","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2125.2001.01328.x","article-title":"Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers","volume":"51","author":"Hagg","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0360","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1067\/mcp.2000.108949","article-title":"No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects","volume":"68","author":"Laine","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0365","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s002280050615","article-title":"CYP2D6 and CYP2C19 activity in a large population of Dutch healthy vol unteers: indications for oral contraceptive-related gender differences","volume":"55","author":"Tamminga","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0370","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2125.1979.tb05905.x","article-title":"Effects of subjects\u2019 sex, and intake of tobacco, alcohol, and oral contraceptives on plasma phenytoin levels","volume":"8","author":"De Leacy","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0375","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2125.1999.00891.x","article-title":"Dose linearity study of selegiline pharmacokinetics after oral administration: evidence for strong drug interaction with female sex steroids","volume":"47","author":"Laine","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0380","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00228-005-0970-1","article-title":"The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects","volume":"61","author":"Bramness","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0385","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1365-2125.2003.01868.x","article-title":"The effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female subjects","volume":"56","author":"Palovaara","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0390","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00228-003-0651-x","article-title":"Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil","volume":"59","author":"McGready","year":"2003","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0395","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.0306-5251.2001.01521.x","article-title":"The effects of an oral contraceptive containing ethinylestradiol and norgestrel on CYP3A activity","volume":"53","author":"Belle","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0400","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2125.2000.00271.x","article-title":"Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1-hydroxylation","volume":"50","author":"Palovaara","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0405","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(87)91988-X","article-title":"Oral contraceptive interaction with cyclosporin","volume":"1","author":"Deray","year":"1987","journal-title":"Lancet"},{"key":"10.1176\/appi.psy.49.2.168_bib0410","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1067\/mcp.2000.105762","article-title":"Edsbacker S: Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol","volume":"67","author":"Seidegard","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0415","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0960-0760(91)90086-K","article-title":"Intrasubject variability in the pharmacokinetics of ethynyloestradiol","volume":"38","author":"Fotherby","year":"1991","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1176\/appi.psy.49.2.168_bib0420","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1056\/NEJM198204013061307","article-title":"Impairment of diazepam metabolism by low-dose, estrogen-containing oral contraceptive steroids","volume":"306","author":"Abernethy","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1176\/appi.psy.49.2.168_bib0425","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/clpt.1984.114","article-title":"Imipramine disposition in users of oral contraceptive steroids","volume":"35","author":"Abernethy","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0430","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0009-8981(87)90161-6","article-title":"Therapeutic drug monitoring of amitriptyline: impact of age, smoking, and contraceptives on drug and metabolite levels in bulimic women","volume":"165","author":"Edelbroek","year":"1987","journal-title":"Clin Chim Acta"},{"key":"10.1176\/appi.psy.49.2.168_bib0435","first-page":"133","article-title":"Diazepam metabolism by cDNA-expressed human 2C P450s: identification of P4502C18 and P4502C19 as low K(M) diazepam N-demethylases","volume":"25","author":"Jung","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1176\/appi.psy.49.2.168_bib0440","first-page":"1199","article-title":"Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and 11 recombinant human CYPs","volume":"281","author":"Koyama","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0445","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/hep.1840030219","article-title":"Differential effects of oral contraceptive steroids on the metabolism of benzodiazepines","volume":"3","author":"Patwardhan","year":"1983","journal-title":"Hepatology"},{"key":"10.1176\/appi.psy.49.2.168_bib0450","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3109\/00498259609050260","article-title":"Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19, and the 3A subfamily","volume":"26","author":"Ono","year":"1996","journal-title":"Xenobiotica"},{"key":"10.1176\/appi.psy.49.2.168_bib0455","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1600-0773.2003.t01-1-930202_93_2.x","article-title":"A screening study on the liability of eight different female sex steroids to inhibit CYP2C9, 2C19, and 3A4 activities in human liver microsomes","volume":"93","author":"Laine","year":"2003","journal-title":"Pharmacol Toxicol"},{"key":"10.1176\/appi.psy.49.2.168_bib0460","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.clpt.2006.01.008","article-title":"Female sex and oral contraceptive use accelerate nicotine metabolism","volume":"79","author":"Benowitz","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0465","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2125.1984.tb02461.x","article-title":"Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination","volume":"18","author":"Miners","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0470","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0306-3623(91)90470-Q","article-title":"Oral contraceptives stimulate the excretion of clofibric acid glucuronide in women and female rats","volume":"22","author":"Liu","year":"1991","journal-title":"Gen Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0475","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2125.1990.tb03750.x","article-title":"Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon","volume":"30","author":"Monig","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0480","first-page":"297","article-title":"Analysis of polymorphic variation in drug metabolism. III: glucuronidation and sulfation of diflunisal in man","volume":"17","author":"Herman","year":"1994","journal-title":"Clin Invest Med"},{"key":"10.1176\/appi.psy.49.2.168_bib0485","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-1211(01)00305-9","article-title":"Lamotrigine plasma levels reduced by oral contraceptives","volume":"47","author":"Sabers","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1176\/appi.psy.49.2.168_bib0490","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1528-1167.2006.00558.x","article-title":"Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy","volume":"47","author":"Contin","year":"2006","journal-title":"Epilepsia"},{"key":"10.1176\/appi.psy.49.2.168_bib0495","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1528-1167.2007.00997.x","article-title":"Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial","volume":"48","author":"Christensen","year":"2007","journal-title":"Epilepsia"},{"key":"10.1176\/appi.psy.49.2.168_bib0500","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1528-1167.2006.00629.x","article-title":"Increased apparent oral clearance of valproic acid during intake of combined contraceptive steroids in women with epilepsy","volume":"47","author":"Galimberti","year":"2006","journal-title":"Epilepsia"},{"key":"10.1176\/appi.psy.49.2.168_bib0505","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/clpt.1983.85","article-title":"Lorazepam and oxazepam kinetics in women on low-dose oral contraceptives","volume":"33","author":"Abernethy","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0510","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/clpt.1984.240","article-title":"Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics","volume":"36","author":"Stoehr","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0515","first-page":"998","article-title":"Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms","volume":"299","author":"Court","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1176\/appi.psy.49.2.168_bib0520","first-page":"48","article-title":"Effects of oral contraceptive steroids on acetaminophen metabolism and elimination","volume":"34","author":"Mitchell","year":"1983","journal-title":"Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0525","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2125.1987.tb03107.x","article-title":"Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol","volume":"23","author":"Rogers","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"10.1176\/appi.psy.49.2.168_bib0530","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1097-010X(199809\/10)282:1\/2<223::AID-JEZ23>3.0.CO;2-T","article-title":"Molecular biology of the human phenol sulfotransferase gene family","volume":"282","author":"Dooley","year":"1998","journal-title":"J Exp Zool"},{"key":"10.1176\/appi.psy.49.2.168_bib0535","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1365-2044.1997.197-az0332.x","article-title":"Taking a \u201cdrugs\u201d history","volume":"52","author":"Hocking","year":"1997","journal-title":"Anaesthesia"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318208709563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318208709563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T23:10:46Z","timestamp":1708729846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318208709563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0033318208709563"],"URL":"https:\/\/doi.org\/10.1176\/appi.psy.49.2.168","relation":{},"ISSN":["0033-3182"],"issn-type":[{"type":"print","value":"0033-3182"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}